Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma
ImmunoTargets and Therapy · 2026-05 · Volume 15 · 1-20
DOI: 10.2147/itt.s605729 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-05. Verfasst von Suiping Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510…. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, People's Republic of China.
- Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
- Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
ORCID-Profile: Jiayu Liu
Zitieren
APA
Liu, S., Wu, J., Liu, J., Wu, K., Huang, Y., Geng, S., Wang, Y., Weng, J., Du, X., & Lai, P. (2026). Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma. ImmunoTargets and Therapy, Volume 15, 1-20. https://doi.org/10.2147/itt.s605729
Vancouver
Liu S, Wu J, Liu J, Wu K, Huang Y, Geng S, et al. Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma. ImmunoTargets and Therapy. 2026;Volume 15:1-20. doi:10.2147/itt.s605729
BibTeX
@article{Liu2026,
author = {Liu, Suiping and Wu, Jieying and Liu, Jiayu and Wu, Kangxiu and Huang, Yanyan and Geng, Suxia and Wang, Yulian and Weng, Jianyu and Du, Xin and Lai, Peilong},
title = {Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma},
journal = {ImmunoTargets and Therapy},
year = {2026},
volume = {Volume 15},
pages = {1--20},
doi = {10.2147/itt.s605729}
}
EUVIMED